Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936637 · ClinicalTrials.gov registry record · NA
Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term
A NA study of Growth, sponsored by Perrigo Nutritionals.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT00936637 is a NA study of Growth that has completed, run by Perrigo Nutritionals. The registered enrollment target is 35 participants, below the 737-participant average among 3 other Growth trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00936637, a NA study of Growth, has completed, sponsored by Perrigo Nutritionals.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.
Conditions Studied
Interventions
- OTHER Extensively hydrolyzed infant formula
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00936637
The ClinicalTrials.gov registry entry for NCT00936637 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 737-participant average among 3 other Growth trials with a reported enrollment target (95% lower). The listed sponsor is Perrigo Nutritionals, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Growth appearing as the primary indexed condition, and to 1 intervention - of which Extensively hydrolyzed infant formula is the first listed.
NCT00936637 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00936637 about?
NCT00936637 is a clinical study titled "Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term". The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.
What is the current status of trial NCT00936637?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2007-07. Estimated completion is 2008-12.
What conditions does trial NCT00936637 study?
This clinical trial studies the following conditions: Growth.
What interventions are being tested in trial NCT00936637?
The interventions under investigation include: Extensively hydrolyzed infant formula (OTHER).
Who is sponsoring clinical trial NCT00936637?
This trial is sponsored by Perrigo Nutritionals, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00936637 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.